0
0
June 7, 2025 — Akay Bioactives, a global leader in natural bioactive ingredients, has announced that its patented fenugreek seed extract, FenuSmart®, has been named the 2025 NutraIngredients Europe “Ingredient of the Year” in the botanicals category. This prestigious recognition highlights FenuSmart’s innovative approach to women’s wellness, particularly its role in supporting hormonal balance and overall well-being across various life stages.
A Breakthrough in Women’s Wellness
FenuSmart® is a clinically substantiated extract derived from fenugreek seeds, formulated to deliver potent bioactives in unique ratios. It is specifically designed to address the evolving needs of women, from their reproductive years through menopause, without relying on synthetic hormones or pharmaceuticals.
Key benefits of FenuSmart® include:
-
Promoting hormonal balance in healthy menstruating women
-
Boosting mood and sexual desire for those in pre-menopause
-
Easing vasomotor discomforts (such as hot flashes) during perimenopause
-
Supporting healthy calcium and hemoglobin levels post-menopause
-
Enhancing emotional, sexual, and mental well-being after menopause
What sets FenuSmart® apart is its robust clinical backing. The ingredient’s efficacy is supported by five published studies, including four randomized controlled trials. These studies demonstrate FenuSmart’s ability to safely modulate hormone levels within the reference range and provide relief from somatic, psychological, and urogenital discomforts commonly experienced by women.
Low Dosage, High Impact
FenuSmart® is effective at a low daily dosage—just 250 mg once or twice per day. Its excellent water-dispersibility makes it suitable for a wide range of nutraceutical products, including gummies, chews, and ready-to-mix beverages. This versatility allows manufacturers to easily incorporate FenuSmart® into popular and convenient wellness formats.
Expert Insights and Future Outlook
Dr. Krishnakumar IM, Chief Research Officer at Akay Bioactives, commented on the achievement:
“We began R&D work for FenuSmart as part of our mission to responsibly transform natural resources into bioactive ingredients with impactful health outcomes. FenuSmart is the result of nearly eight years of systematic research, and receiving this award is both encouraging and inspiring. It reinforces our commitment to developing effective, plant-based ingredients through leading-edge technologies and rigorous clinical research. We believe the scientific community has only just begun to unlock the full potential of fenugreek, an extraordinary medicinal herb. You can expect much more from us in the years ahead.”
Disclaimer
This article is for informational purposes only and does not constitute medical advice. The claims regarding FenuSmart® are based on clinical studies referenced by Akay Bioactives and have not been evaluated by all regulatory authorities. Individuals should consult with healthcare professionals before starting any new supplement, especially those with underlying health conditions or those taking medication.
